Skip to main content
Fig. 10 | Hereditas

Fig. 10

From: Deciphering the potential ability of RG108 in cisplatin-induced HEI-OC1 ototoxicity: a research based on RNA-seq and molecular biology experiment

Fig. 10

MTT assay was used to detect the difference in the activity of PI3K and AKT inhibitors co treated with cisplatin. A Determination of cell viability in LY294002 treatment group. B Determination of cell viability in Wortmannin treatment group. C Determination of cell viability in MK-2206 treatment group. D Determination of cell viability in A-674563 treatment group. Data are expressed as mean ± SD, n = 3,**** P < 0.0001 compared with the control group. Compared with cisplatin group, ##P < 0.01. ### P < 0.001.####p < 0.0001. scale: 100 μ m

Back to article page